Loading...

PE/Cyanine7 anti-mouse CD80 Antibody

Pricing & Availability
Clone
16-10A1 (See other available formats)
Regulatory Status
RUO
Other Names
B7-1, B7, Ly-53
Isotype
Armenian Hamster IgG
Ave. Rating
Submit a Review
Product Citations
publications
16-10A1_PECy7_CD80_Antibody_FC_012314.jpg
LPS-stimulated (day 3) C57BL/6 mouse splenocytes were stained with CD80 (clone 16-10A1) PE/Cyanine7 (filled histogram) or Armenian hamster IgG PE/Cyanine7 isotype control (open histogram).
  • 16-10A1_PECy7_CD80_Antibody_FC_012314.jpg
    LPS-stimulated (day 3) C57BL/6 mouse splenocytes were stained with CD80 (clone 16-10A1) PE/Cyanine7 (filled histogram) or Armenian hamster IgG PE/Cyanine7 isotype control (open histogram).
See PE/Cyanine7 spectral data
Cat # Size Price Quantity Check Availability Save
104733 25 µg 116 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
104734 100 µg 292 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD80 is a 60 kD highly glycosylated protein. It is a member of the Ig superfamily and is also known as B7-1, B7, and Ly-53. CD80 is constitutively expressed on dendritic cells and monocytes/macrophages, and inducibly expressed on activated B and T cells. The ligation of CD28 on T cells with CD80 and CD86 (B7-2) on antigen presenting cells (such as dendritic cells, macrophages, and B cells) elicits co-stimulation of T cells resulting in enhanced cell activation, proliferation, and cytokine production. CD80 appears to be expressed later in the immune response than CD86. CD80 can also bind to CD152, also known as CTLA-4, to deliver an inhibitory signal to T cells.

Product Details
Technical Data Sheet (pdf)

Product Details

Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
CHO cell line transfected with mouse B7 (CD80)
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography and conjugated with PE/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.5 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation2, in vitro and in vivo blocking of CTLA-4 Ig to CD80 by blocking costimulation of T cells by activated B cells2-4, and immunohistochemical staining of acetone-fixed frozen sections1,4. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. Nos. 104747-104752).

Additional Product Notes
BioLegend is in the process of converting the name PE/Cy7 to PE/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our PE/Cyanine7 products. Please contact Technical Service if you have any questions.
Application References

(PubMed link indicates BioLegend citation)
  1. Harlan DM, et al. 1994. P. Natl. Acad. Sci. USA 91:3137. (IHC)
  2. Razi-Wolf Z, et al. 1992. P. Natl. Acad. Sci. USA 89:4210. (Block, IP)
  3. Hathcock KS, et al. 1994. J. Exp. Med. 180:631. (Block)
  4. Herold KC, et al. 1997. J. Immunol. 158:984. (Block, IHC)
  5. Ma XT, et al. 2006. Cancer Res. 66:1169.
  6. Andoniou CE, et al. 2005. Nature Immunology 6:1011. (FC)
  7. Lawson BR, et al. 2007. J. Immunol. 178:5366.
  8. Turnquist HR, et al. 2007. J. Immunol. 178:7018.
  9. Misra RS, et al. 2010. J. Exp Med. 207:1775. PubMed
  10. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
  11. Philipsen L, et al. 2013. Mol Cell Proteomics. 12:2551. PubMed
Product Citations
  1. Haikala HM, et al. 2019. Nat Commun. 10:620. PubMed
  2. Kiyohara H, et al. 2018. Cell Mol Gastroenterol Hepatol. 7:135. PubMed
  3. Ding X, et al. 2019. J Am Heart Assoc. 8:e011211. PubMed
  4. Paraiso HC, et al. 2018. J Neuroinflammation. 0.694444444. PubMed
  5. Zhao Y, et al. 2020. Immunity. 51(6):1059-1073.e9.. PubMed
  6. Cullis J, et al. 2017. Cancer Immunol Res. 5:182. PubMed
  7. Wang S, et al. 2018. Biomaterials. 187:28:00. PubMed
  8. Utz B, et al. 2020. Sci Rep. 10:18733. PubMed
  9. Wang X, et al. 2020. Nat Commun. 4.505555556. PubMed
  10. Deerhake ME, et al. 2021. Immunity. 54(3):484-498.e8. PubMed
  11. Siolas D, et al. 2021. Cell Reports. 36:109578. PubMed
  12. McNamara HA, et al. 2020. Cell Host Microbe. 572:28. PubMed
  13. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  14. Guo Y, et al. 2021. Nat Immunol. 22:746. PubMed
  15. Guo S, et al. 2021. Sci Rep. 11:23745. PubMed
  16. Zhang W, et al. 2021. Front Immunol. 12:768435. PubMed
  17. Ishikura N, et al. 2022. Oncol Rep. 47:. PubMed
  18. Wang R, et al. 2022. J Immunother Cancer. 10:. PubMed
  19. Teng ZX, et al. 2022. J Inflamm Res. 15:3187. PubMed
  20. Li H, et al. 2022. iScience. 25:104481. PubMed
  21. Chen J, et al. 2022. J Nanobiotechnology. 20:283. PubMed
  22. Akazawa S, et al. 2021. Diabetologia. 64:878. PubMed
  23. Germundson DL, et al. 2022. Front Allergy. 3:870513. PubMed
  24. Padonou F, et al. 2022. EMBO Rep. 23:e53576. PubMed
  25. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  26. Zenke S, et al. 2022. Nat Commun. 13:6459. PubMed
  27. Wang W, et al. 2022. Dev Cell. 57:228. PubMed
  28. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  29. Manda-Handzlik A, et al. 2022. Int J Mol Sci. 23: . PubMed
  30. Wang W, et al. 2022. Cell Rep. 41:111582. PubMed
  31. Kumpunya S, et al. 2023. Front Immunol. 13:1010764. PubMed
  32. Liu H, et al. 2023. Cell Death Differ. :. PubMed
  33. Chen X, et al. 2023. Adv Mater. 35:e2210440. PubMed
  34. Li Y, et al. 2023. Adv Mater. 35:e2208923. PubMed
  35. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  36. Kaur N, et al. 2023. Heliyon. 9:e14952. PubMed
  37. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
RRID
AB_2563112 (BioLegend Cat. No. 104733)
AB_2563113 (BioLegend Cat. No. 104734)

Antigen Details

Structure
Ig superfamily, 60 kD
Distribution

Macrophages, activated B cells and T cells, dendritic cells

Function
T cell costimulation
Ligand/Receptor
CD28 (stimulatory), CD152(CTLA4) (inhibitory)
Cell Type
B cells, Dendritic cells, Macrophages, T cells, Tregs
Biology Area
Cell Biology, Costimulatory Molecules, Immunology, Neuroscience, Neuroscience Cell Markers
Molecular Family
CD Molecules, Immune Checkpoint Receptors
Antigen References

1. Barclay AN, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Linsley PS, et al. 1991. J. Exp. Med. 174:561.
3. Salomon B, et al. 2001. Annu. Rev. Immunol. 19:225.

Gene ID
12519 View all products for this Gene ID
UniProt
View information about CD80 on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 1    Revision Date: 01.31.2014

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account